Edition:
United States

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

6.62CNY
23 Feb 2018
Change (% chg)

¥0.00 (+0.00%)
Prev Close
¥6.62
Open
¥6.64
Day's High
¥6.65
Day's Low
¥6.59
Volume
3,277,016
Avg. Vol
12,504,632
52-wk High
¥8.00
52-wk Low
¥6.15

Chart for

About

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.83
Market Cap(Mil.): ¥17,657.66
Shares Outstanding(Mil.): 2,667.32
Dividend: 0.12
Yield (%): 1.81

Financials

  Industry Sector
P/E (TTM): -- 30.98 16.31
EPS (TTM): -- -- --
ROI: -- 14.12 35.74
ROE: -- 15.72 17.71

BRIEF-Zhejiang Conba Pharmaceutical issues 156.6 mln shares and raises 1.09 bln yuan

* Says it issued 156.6 million shares and raised 1.09 billion yuan in total, via private placement

Jan 12 2018

BRIEF-Zhejiang Conba Pharmaceutical Sees 2017 Net Profit Up 60-80 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 60-80 PERCENT Y/Y FROM 441.1 MILLION YUAN ($67.65 million) YEAR AGO Source text in Chinese: http://bit.ly/2CRWSBQ Further company coverage: ($1 = 6.5205 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Jan 09 2018

BRIEF-Zhejiang Conba Pharmaceutical two units obtains high-tech enterprise recognition

* Says its two wholly owned Guizhou and Inner Mongolia-based pharma units obtains high-tech enterprise recognition, to enjoy a tax preference of 15 percent for three years from 2017 to 2019

Dec 22 2017

BRIEF-Zhejiang CONBA Pharmaceutical's 9-month net profit up 34.9 pct y/y

* Says 9-month net profit up 34.9 percent y/y at 607.1 million yuan ($91.74 million)

Oct 17 2017

BRIEF-Zhejiang Conba Pharmaceutical gets approval to issue 1.5 bln yuan medium-term notes

* Says it gets approval to issue 1.5 billion yuan ($228.81 million) medium-term notes

Sep 18 2017

Earnings vs. Estimates